SCHEDULE: Blackstone Entities Adjust Autolus Holdings Post-Warrant Expiry

Blackstone entities have amended their Schedule 13D filing for Autolus Therapeutics plc, reflecting a reduced beneficial ownership percentage following the expiration of warrants.

Summary

• This filing is an amendment (Amendment No. 3) to a Schedule 13D for Autolus Therapeutics plc, concerning American Depositary Shares (ADSs) representing ordinary shares.
• The amendment updates the beneficial ownership of several Blackstone entities and Stephen A. Schwarzman.
• The primary reason for the amendment is the expiration of 3,265,306 ADSs subject to a Warrant Instrument on November 6, 2026.
• This expiration has reduced the aggregate beneficial ownership percentage of the reporting persons to 7.6% from a previously higher percentage.
• The total number of ADSs beneficially owned by BXLS V - Autobahn L.P. is 20,485,611, representing 7.6% of the outstanding shares.
• The filing clarifies the reporting structure and relationships among the various Blackstone entities involved.
• No new transactions in Ordinary Shares or ADSs were made by the reporting persons in the past 60 days, and no legal proceedings are disclosed.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the expiration of warrants, which reduces the reporting persons' beneficial ownership percentage without a corresponding increase in shares held.

Positives

• The reporting persons continue to hold a significant stake in Autolus Therapeutics plc, indicating ongoing confidence in the company's long-term prospects.
• The structure of the filing and the clarity provided on the reporting persons' relationships are positive for transparency.

Negatives

• The expiration of warrants has led to a decrease in the reported beneficial ownership percentage, which could be perceived negatively by the market.
• The reduction in ownership percentage, even if due to warrant expiry, might signal a shift in the reporting persons' strategic positioning or a lack of further investment intent through warrants.

Risks

• The expiration of warrants means a reduction in the potential for future share acquisition through these instruments, impacting the reporting persons' effective stake.
• While not explicitly stated as a risk, the decrease in ownership percentage could be interpreted by the market as a reduced commitment or a precursor to further divestment, potentially impacting share price.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from the company itself. It primarily serves to update ownership information due to the expiration of warrants.

Management Comments

• Each Reporting Person may be deemed to beneficially own the securities of the Issuer directly held by BXLS V - Autobahn L.P.
• Neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission that any Reporting Person is the beneficial owner of the ADSs referred to herein for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or for any other purpose and each of the Reporting Persons expressly disclaims beneficial ownership of such ADSs.
• The filing of this statement should not be construed to be an admission that any member of the Reporting Persons are members of a 'group' for the purposes of Sections 13(d) and 13(g) of the Exchange Act.

Industry Context

StockSavvy.ai notes that Schedule 13D filings are common for significant institutional investors like Blackstone when their ownership stake crosses certain thresholds or changes materially. The expiration of warrants is a standard event that can alter beneficial ownership percentages without a direct transaction, impacting reporting requirements.

Stakeholder Impact

• Shareholders: The reduced ownership percentage by a major investor might be interpreted in various ways, potentially influencing market sentiment, though the underlying share count held by the investor remains the same.
• Blackstone Entities: The filing accurately reflects their current beneficial ownership status after warrant expiration, ensuring compliance with regulatory requirements.
• Autolus Therapeutics plc Management: The filing provides clarity on the ownership structure of a significant stakeholder.

Next Steps

• The reporting persons will continue to monitor their beneficial ownership in Autolus Therapeutics plc and file amendments to Schedule 13D as required by SEC regulations.
• The company, Autolus Therapeutics plc, will continue its operations and business development as outlined in its other public filings.

Key Dates

Keywords

Autolus Therapeutics, Blackstone, Schedule 13D, Beneficial Ownership, Warrants, ADSs, Investment